Polypoid invasive carcinoma of the gallbladder-Another challenging polypoid neoplasm.


Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
May 2022
Historique:
revised: 29 08 2021
received: 20 07 2021
accepted: 03 09 2021
pubmed: 30 9 2021
medline: 3 6 2022
entrez: 29 9 2021
Statut: ppublish

Résumé

Invasive gallbladder carcinoma generally presents as nodular-sclerosing growth. Recently, "polypoid invasive carcinoma (PICA)" showing grossly visible polypoid neoplasm and histologically invasive carcinoma with no adenomatous components was proposed as a neoplastic polyp of the gallbladder. We herein report five cases of PICA collected from 49 cases of invasive gallbladder carcinoma in comparison with another polypoid preinvasive neoplasm of gallbladder, intracholecystic papillary neoplasm (ICPN). Polypoid invasive carcinomas were composed of four males and one female with an average age of 74 years. Polypoid lesions were sessile (height ranging from 6 to 10 mm and the largest diameter ranging from 12 to 40 mm), and histologically, polypoid neoplasms presented papillary configuration containing tubular and cribriform components with thin inflammatory, fibrotic stroma. Polypoid carcinoma invaded directly and continuously into the gallbladder wall with destruction of the muscle layer. These patterns of PICA were different from ICPN, showing papillary patterns containing tubular components with fine fibrovascular stalks and with occasional focal stromal invasion but with preserved muscle layer. Post-operative outcome was not favorable in PICA but was favorable in ICPN. Polypoid invasive carcinoma shared several pathological features with ICPN, such as intraluminal polypoid pattern with papillary configurations, but PICAs were invasive adenocarcinoma with destruction of muscle layer while ICPNs were preinvasive neoplasm with occasional focal stromal invasion, thus both should be differentiated from each other.

Sections du résumé

BACKGROUND BACKGROUND
Invasive gallbladder carcinoma generally presents as nodular-sclerosing growth. Recently, "polypoid invasive carcinoma (PICA)" showing grossly visible polypoid neoplasm and histologically invasive carcinoma with no adenomatous components was proposed as a neoplastic polyp of the gallbladder.
METHODS METHODS
We herein report five cases of PICA collected from 49 cases of invasive gallbladder carcinoma in comparison with another polypoid preinvasive neoplasm of gallbladder, intracholecystic papillary neoplasm (ICPN).
RESULTS RESULTS
Polypoid invasive carcinomas were composed of four males and one female with an average age of 74 years. Polypoid lesions were sessile (height ranging from 6 to 10 mm and the largest diameter ranging from 12 to 40 mm), and histologically, polypoid neoplasms presented papillary configuration containing tubular and cribriform components with thin inflammatory, fibrotic stroma. Polypoid carcinoma invaded directly and continuously into the gallbladder wall with destruction of the muscle layer. These patterns of PICA were different from ICPN, showing papillary patterns containing tubular components with fine fibrovascular stalks and with occasional focal stromal invasion but with preserved muscle layer. Post-operative outcome was not favorable in PICA but was favorable in ICPN.
CONCLUSIONS CONCLUSIONS
Polypoid invasive carcinoma shared several pathological features with ICPN, such as intraluminal polypoid pattern with papillary configurations, but PICAs were invasive adenocarcinoma with destruction of muscle layer while ICPNs were preinvasive neoplasm with occasional focal stromal invasion, thus both should be differentiated from each other.

Identifiants

pubmed: 34586747
doi: 10.1002/jhbp.1051
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-539

Informations de copyright

© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Références

WHO Classification of Tumours Editorial Board. WHO Classification of Tumours, 5th edn. Lyon, FR: Digestive System Tumours. International Agency for Reearch on Cancer; 2019.
Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours, 4th edn. Lyon, FR: Digestive System Tumours. International Agency for Research on Cancer; 2010.
Nakanuma Y, Sugino T, Okamura Y, Nomura Y, Watanabe H, Terada T, et al. Characterization of high-grade biliary intraepithelial neoplasm of the gallbladder in comparison with intracholecystic papillary neoplasm. Hum Pathol. 2021;116:22-30.
Nakanuma Y, Nomura Y, Watanabe H, Terada T, Sato Y, Kakuda Y, et al. Pathological characterization of intracholecystic papillary neoplasm: a recently proposed preinvasive neoplasm of gallbladder. Ann Diagn Pathol. 2021;52:151723. https://doi.org/10.1016/j.anndiagpath.2021.151723. Online ahead of print. PMID: 33725666
Pehlivanoglu B, Balci S, Basturk O, Bagci P, Erbarut Seven I, et al. Intracholecystic tubular non-mucinous neoplasm (ICTN) of the gallbladder: a clinicopathologically distinct, invasion-resistant entity. Virchows Arch. 2021;478:435-47.
He C, Fukumura Y, Toriyama A, Ogura K, Sasahara N, Mitani K, et al. Pyloric Gland Adenoma (PGA) of the gallbladder: a unique and distinct tumor from PGAs of the stomach, duodenum, and pancreas. Among authors: Fukumura Y. Am J Surg Pathol. 2018;42:1237-45.
Taskin OC, Basturk O, Reid MD, Dursun N, Bagci P, Saka B, et al. Gallbladder polyps: correlation of size and clinicopathologic characteristics based on updated definitions. PLoS One. 2020;15(9):e0237979.
Aloia TA, Járufe N, Javle M, Maithel SK, Roa JC, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681-90.
Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Vaterian System. Wshington, DC. American Registry of Pathology; 2015 (AFIP atlas oftumor pathology, series 4; fascicle 23).
Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are 1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol. 2012;36:1279-1.
Wan X, Zhang H, Chen C, Yang X, Wang A, Zhu C, et al. Clinicopathological features of gallbladder papillary adenocarcinoma. Medicine (Baltimore). 2014;93(27):e131.
Akita M, Fujikura K, Ajiki T, Fukumoto T, Otani K, Hirose T, et al. Intracholecystic papillary neoplasms are distinct from papillary gallbladder cancers: a clinicopathologic and exome-sequencing study. Am J Surg Pathol. 2019;43:783-91.
Onoe S, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, et al. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases. HPB (Oxford). 2021;23(8):S1365-S182X(21)00071-X.
Albores-Saavedra J, Tuck M, McLaren BK, Carrick KS, Henson DE. Papillary carcinomas of the gallbladder: analysis of noninvasive and invasive types. Arch Pathol Lab Med. 2005;129:905-9.
Lack EE. Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tract, and Ampullary Region. Oxford University Press; 2003. pp. 1-586.
Mochidome N, Koga Y, Ohishi Y, Miyazaki T, Matsuda R, Yamada Y, et al. Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer. Hum Pathol. 2021;114:44-53.

Auteurs

Yasuni Nakanuma (Y)

Department of Diagnostic Pathology, Shizuoka Cancer Center, Sunto-gun, Japan.
Department of Diagnostic Pathology, Fukui Prefecture institute, Fukui, Japan.

Takashi Sugino (T)

Department of Diagnostic Pathology, Shizuoka Cancer Center, Sunto-gun, Japan.

Yoshikatsu Nomura (Y)

Department of Digestive Medicine, Fukui-ken Saiseikai Hospital, Fukui, Japan.

Hiroyuki Watanabe (H)

Department of Digestive Medicine, Fukui-ken Saiseikai Hospital, Fukui, Japan.

Takuro Terada (T)

Department of Digestive Surgery, Fukui Prefecture Saiseikai Hospital, Fukui, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH